Search Filters

Search Results

Found 9 results

510(k) Data Aggregation

    K Number
    K201511
    Date Cleared
    2020-07-31

    (56 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Reprocessed Endoscopic Trocars and Sleeves

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Reprocessed Endoscopic Trocars and Sleeves (B11LT, B12LT, B5LT, CB11LT, CB12LT, CB5LT, CB5ST, D11LT, D12LT, D5LT, D5ST, H12LP, 2B5LT, 2B5ST, 2D5LT, 2CB5ST, 2CB5LT) have applications in abdominal, thoracic, and gynecologic minimally invasive surgical procedures to establish a path of entry for endoscopic instruments. The Bladeless Trocars may be used with or without visualization for primary and secondary insertions.

    Device Description

    The Reprocessed Endoscopic Trocars and Sleeves (B11LT, B12LT, B5LT, B5ST, CB11LT, CB12LT, CB5LT, CB5ST, D11LT, D12LT, D5LT, D5ST, H12LP, 2B5LT, 2B5ST, 2D5LT, 2D5ST, 2CB5ST, 2CB5LT) are sterile, single patient use instruments consisting of a radiolucent sleeve (cannula) and obturators in sizes ranging from 5-12 mm in diameter. There different obturators; Bladeless, Dilating Tip (Bladed) and Blunt Tip. The bladeless obturator contains a clear, tapered optical element, and when used with an endoscope provides visibility of individual tissue layers during insertion. The Dilating Tip (Bladed) obturator has a sharp, flat-bladed tip and spring-loaded shield. The shield is designed to cover the flat-bladed tip to protect internal structures from puncture or laceration once the abdominal or thoracic cavity has been entered. The Blunt Tip obturator has a blunt plastic tip which gently moves aside any viscera that may be adjacent to abdominal or thoracic wall.

    The trocar sleeve contains two seals that accommodate instruments. Together, these two seals minimize gas leakage when instruments are inserted or withdrawn through the trocar. Please note that the 5mm bladeless trocar cannula without Optiview Technology does not have the outer integrated self-adjusting seal and only accommodates 5mm instruments. A stopcock valve is compatible with standard luer lock fittings and provides attachment for gas insufflation and desufflation. The stopcock is in the closed position when it is parallel to the sleeve.

    Trocars with Optiview Technology incorporates a design enhancement that reduces the incidence of trocar induced endoscope lens smudging during endoscope insertion.

    The Reprocessed Sleeves are sterile, single patient use devices with a radiolucent sleeve (cannula). The trocar sleeve contains two seals that accommodate instruments. Together, these two seals minimize qas leakage when instruments are inserted or withdrawn through the trocar. Please note that the 5mm trocar cannula without Optiview Technology does not have the outer integrated self-adjusting seal and only accommodates 5mm instruments. A stopcock valve is compatible with standard luer lock fittings and provides attachment for gas insufflation and desufflation. The stopcock is in the closed position when it is parallel to the sleeve.

    AI/ML Overview

    The provided text is a 510(k) summary for the reprocessing of endoscopic trocars and sleeves. It outlines the device description, indications for use, and a comparison to predicate devices, focusing on the equivalence of the reprocessed devices to the original, new devices. However, the document does NOT contain information about a study proving the device meets acceptance criteria in the way one might expect for a digital health or AI/ML-enabled medical device, as it's not evaluating algorithm performance.

    Instead, this document describes the validation of reprocessing for a physical medical device. The "acceptance criteria" here refer to the performance standards that the reprocessed physical device must meet to demonstrate it is "at least as safe and effective" as the original, new device.

    Therefore, I will interpret the request in the context of the provided document, addressing the closest equivalents to the requested information. It's important to note that many of the requested fields (e.g., number of experts for ground truth, MRMC study, training set sample size) are not applicable to the type of device and study described in this 510(k) summary.


    Acceptance Criteria and Study for Reprocessed Endoscopic Trocars and Sleeves

    The document describes the regulatory submission for the reprocessing of Endoscopic Trocars and Sleeves, asserting their substantial equivalence to predicate (new) devices. The acceptance criteria and the "study" proving this equivalence are based on a set of bench and laboratory tests designed to demonstrate that the reprocessed devices maintain their original performance, safety, and effectiveness.

    1. A table of acceptance criteria and the reported device performance

    The document does not provide a quantitative table of acceptance criteria and reported numerical performance values for each test. Instead, it lists the types of performance tests conducted and then makes a general statement about their outcome. The implicit acceptance criterion for each test is that the reprocessed device performs comparably to the new device and maintains its safety and effectiveness.

    CategorySpecific Test / CriterionReported Device Performance
    BiocompatibilityBiocompatibility testing. (Implicit criterion: no unacceptable biological risk introduced by reprocessing).Conducted. (Implicitly: The reprocessed devices meet biocompatibility standards and are as safe as the predicate devices).
    Reprocessing Valid.Validation of Reprocessing (e.g., cleaning efficacy, material compatibility after reprocessing cycles). (Implicit criterion: reprocessing effectively cleans and does not degrade the device below performance standards, with a limit of 1 reprocessing cycle).Conducted. The devices are reprocessed no more than one (1) time. Each reprocessed device is tracked and rejected if it reaches the maximum number of cycles. Reprocessing is restricted to devices not previously reprocessed by others. (Implicitly: Validated as effective).
    Sterilization Valid.Sterilization Validation (e.g., sterility assurance level, material compatibility with sterilization method). (Implicit criterion: device maintains sterility after reprocessing and sterilization without degradation).Conducted. (Implicitly: Devices are sterile by Ethylene Oxide and maintain their integrity).
    Functional Performance- Device Aesthetics
    • Peak Insertion Force
    • Stability Plug Clip Integrity
    • Stability Plug Clamp Integrity
    • Trocar Leak Test
    • Obturator Engagement
    • Cannula Housing Integrity
    • Obturator Housing Integrity
    • Cannula Sleeve Integrity
    • Insertion/Withdrawal Forces - Obturator to Cannula
    • Device Integrity
    • Peak Insertion Force
    • Obturator Engagement
    • Shield Lock Engagement Force
    • Blade Shield Engagement | Bench and laboratory testing were conducted to demonstrate performance. The performance testing demonstrates that reprocessed devices are as safe and effective as the predicate and operate as originally intended. |
      | Aging/Durability | (Implicit criterion: device functions after reprocessing and maintains properties for intended shelf life). | Reprocessed no more than one (1) time; implies that performance is maintained for this single reprocessing cycle. |
      | Packaging Validation | Packaging Validation. (Implicit criterion: packaging maintains sterility and device integrity). | Conducted. |

    2. Sample size used for the test set and the data provenance

    The document does not specify the exact sample sizes for each of the conducted tests (e.g., number of reprocessed trocars tested for leak, insertion force, etc.).
    The data provenance is from bench and laboratory testing conducted by Stryker Sustainability Solutions. It is prospective in the sense that the tests were specifically performed to support this 510(k) submission, not retrospectively analyzed from existing data. The country of origin for the testing is not explicitly stated but can be inferred as the United States, given the FDA submission.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This question is not applicable in the context of this device and study. The "ground truth" for a reprocessed physical device is established by engineering specifications, material properties, and functional performance benchmarks derived from the original, new predicate devices. It does not involve expert readers reviewing images or clinical data for diagnosis. The "experts" involved are likely engineers, quality assurance personnel, and regulatory affairs specialists who designed and executed the tests and evaluated the results against objective performance standards.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This question is not applicable. Adjudication methods like 2+1 or 3+1 are used in studies involving human interpretation (e.g., radiologists reviewing medical images) to establish a consensus ground truth. For physical device performance testing, acceptance is determined by meeting pre-defined quantitative or qualitative engineering specifications, not human consensus on a clinical outcome.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This question is not applicable. This is a submission for a reprocessed physical medical device, not an AI/AI-assisted device. Therefore, no MRMC study looking at human reader improvement with AI assistance was performed.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This question is not applicable. This is a physical medical device, not an algorithm.

    7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)

    The "ground truth" for this device's performance is based on engineering specifications and functional performance characteristics of the original, new predicate devices. The reprocessed devices are tested to ensure they maintain these validated characteristics. This includes:

    • Physical dimensions and integrity
    • Mechanical function (e.g., insertion force, leak tests, engagement of components)
    • Material properties (implied by biocompatibility and sterilization validation)
    • Sterility

    Essentially, the ground truth is the "performance profile of a new, unused device."

    8. The sample size for the training set

    This question is not applicable. This is a physical medical device undergoing reprocessing validation, not an AI/ML algorithm that requires a training set.

    9. How the ground truth for the training set was established

    This question is not applicable for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    K Number
    K121240
    Manufacturer
    Date Cleared
    2012-06-11

    (48 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    REPROCESSED ENDOSCOPIC TROCARS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The reprocessed endoscopic trocars are designed to provide a pathway for entry of minimally invasive instruments to a body organ or cavity during general, abdominal, thoracic, gynecologic or other minimally invasive surgical procedures such as observation, dissecting, cutting, repairing, and removal or manipulation of internal tissues and/or organs.

    Device Description

    The reprocessed endoscopic trocar is a sterile instrument consisting of a sleeve and obturator that is available in varying lengths and diameters. The obturator may be bladeless or dilating tip. Reprocessed trocars are devices that provide a pathway for entry of minimally invasive instruments to a body organ or cavity during general, abdominal, thoracic, gynecologic, or other minimally invasive surgical procedures.

    AI/ML Overview

    This document describes the 510(k) premarket notification for Reprocessed Endoscopic Trocars by Sterilmed, Inc. The submission aims to demonstrate substantial equivalence to a predicate device.

    Here's an analysis of the provided information, focusing on acceptance criteria, study details, and ground truth establishment:

    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not explicitly present a table of quantitative acceptance criteria with corresponding reported device performance metrics in the format typically seen for algorithm performance (e.g., sensitivity, specificity, AUC). Instead, the acceptance criteria are implicitly defined by demonstrating that the reprocessed devices perform "as originally intended" and are "substantially equivalent" to the predicate device in terms of functional and safety characteristics.

    The reported device performance is described qualitatively and through validation studies.

    Acceptance Criteria CategoryReported Device Performance (Summary of Non-clinical Tests Conducted)
    Cleaning ValidationCleaning validation was performed.
    Sterilization ValidationSterilization validation was performed (ISO 11135, USP ).
    BiocompatibilityBiocompatibility testing was performed (ISO 10993).
    Ethylene Oxide ResidualEthylene oxide residual testing was performed (ISO 10993-7).
    Packaging ValidationPackaging validation was performed (ASTM D 4169, ASTM F 88, ASTM F 2096).
    Shelf Life ValidationShelf life validation was performed (ASTM 1980-07).
    Functional PerformanceValidation of functional performance (bench testing) was performed through simulated use, visual inspection, fatigue testing, and function testing. "Performance testing shows the reprocessed endoscopic trocar to perform as originally intended."
    Substantial Equivalence"Sterilmed concludes that the reprocessed endoscopic trocars are safe, effective, and substantially equivalent to the predicate devices, Ethicon Endo-Surgery ENDOPATH® XCEL™ With OPTIVIEW® Technology Trocars (K032676), as described in this premarket notification submission."
    Technological EquivalenceThe reprocessed trocars are "identical to the predicate devices in design, materials of construction (except for the absorbent ring which is non-patient contact), and intended use. There are no changes to the clinical applications, patient population, performance specifications, or method of operation."

    2. Sample Size Used for the Test Set and Data Provenance

    The document states "Representative samples of reprocessed endoscopic trocars were tested to demonstrate appropriate functional characteristics." However, it does not provide a specific numerical sample size for the test set used for functional and safety testing. Similarly, the data provenance (country of origin, retrospective/prospective) is not explicitly stated, but the submission is from Sterilmed, Inc. in Maple Grove, MN, implying testing likely occurred in the US. The nature of the validation (cleaning, sterilization, functional bench testing) suggests these were performed in a controlled laboratory or manufacturing environment, rather than being clinical trial data.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This type of information is not applicable to this submission. The validation of reprocessed medical devices focuses on engineering and scientific testing (e.g., microbiology for sterilization, chemical analysis for residuals, mechanical testing for function), not on expert clinical interpretation of results against a "ground truth" established by human experts in the way AI/ML medical devices are assessed.

    4. Adjudication Method for the Test Set

    This is not applicable as the evaluation relies on objective laboratory and bench testing rather than clinical interpretation requiring adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done

    No, a MRMC comparative effectiveness study was not done. This type of study is relevant for evaluating the impact of AI on human reader performance, typically for diagnostic imaging. This submission concerns the reprocessing and functional validation of physical medical devices.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    This is not applicable. This is a submission for a reprocessed physical medical device, not a software algorithm.

    7. The Type of Ground Truth Used

    The "ground truth" in this context is established through objective scientific and engineering standards and methods. This includes:

    • Established standards: ISO 11135, USP for sterilization, ISO 10993 for biocompatibility, ISO 10993-7 for ethylene oxide residuals, ASTM D 4169, ASTM F 88, ASTM F 2096 for packaging, ASTM 1980-07 for shelf life.
    • Bench testing: Functional performance is assessed against the original performance specifications of the predicate device.
    • Visual inspection: Conformance to physical and material specifications.
    • Simulated use and fatigue testing: Evaluation of performance under conditions mimicking clinical use.

    The ground truth is that the reprocessed device must meet the same performance, safety, and material characteristics as the new predicate device, and these are verified through the outlined non-clinical tests.

    8. The Sample Size for the Training Set

    This is not applicable. There is no "training set" in the context of validating a reprocessed physical medical device as there is no AI/ML model being developed. The processes (cleaning, sterilization) are validated, not trained.

    9. How the Ground Truth for the Training Set was Established

    This is not applicable for the reasons stated in point 8.

    Ask a Question

    Ask a specific question about this device

    K Number
    K111002
    Manufacturer
    Date Cleared
    2011-07-18

    (98 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    REPROCESSED ENDOSCOPIC TROCARS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The reprocessed endoscopic trocars are designed to provide a pathway for entry of minimally invasive instruments to a body organ or cavity during general, abdominal, thoracic, gynecologic or other minimally invasive surgical procedures.

    Device Description

    The reprocessed endoscopic trocar is a sterile instrument consisting of a sleeve and obturator that is available in varying lengths and diameters. The obturator may be blunt, bladed, or shielded-bladed (blade covered by a retractable shield). Reprocessed endoscopic trocars are devices that provide a pathway for entry of minimally invasive instruments to a body organ or cavity during abdominal, thoracic or gynecologic surgical procedures.

    AI/ML Overview

    The provided text is a 510(k) summary for SterilMed, Inc.'s reprocessed endoscopic trocars. It focuses on demonstrating substantial equivalence to predicate devices rather than providing detailed acceptance criteria and a study to prove device performance in the context of an AI/ML device.

    Therefore, the information required for the requested output (acceptance criteria table, sample sizes, ground truth establishment, MRMC studies, etc.) is not present in the provided document. The document describes a traditional medical device reprocessing and its approval process, not an AI/ML device study.

    Here's a breakdown of what is available vs. what is not:

    What is present:

    • Device Description: Reprocessed endoscopic trocar, consisting of a sleeve and obturator.
    • Intended Use: To provide a pathway for entry of minimally invasive instruments to a body organ or cavity during various surgical procedures.
    • Functional and Safety Testing mentioned: Cleaning validation, sterilization validation (ISO 11135, USP ), biocompatibility testing (ISO 10993), ethylene oxide residual testing (ISO 10993-7), packaging validation (ASTM D4169, ASTM F88, ASTM F2096), shelf life validation (ASTM 1980-07), and functional performance validated using bench and laboratory testing.
    • Conclusion: Substantial equivalence to predicate devices based on similarities in functional design, materials, indications for use, and methods of construction.

    What is NOT present (and is required for your requested output, indicating this is not an AI/ML study report):

    • Specific Acceptance Criteria (quantitative metrics like sensitivity, specificity, AUC, etc. for an AI model). The document mentions "appropriate functional characteristics" but doesn't quantify them.
    • Reported Device Performance against specific quantitative criteria.
    • Sample Size for a test set (in terms of cases/images for an AI model). The document mentions "representative samples" for functional testing but not a quantified test set for AI evaluation.
    • Data Provenance (country of origin, retrospective/prospective for AI data).
    • Number of experts and their qualifications for establishing ground truth. This typically applies to AI model evaluation where human experts label data.
    • Adjudication method (2+1, 3+1, none) for a test set.
    • Multi-Reader Multi-Case (MRMC) comparative effectiveness study, including effect size. This is specific to human-AI collaboration studies.
    • Standalone (algorithm-only) performance data.
    • Type of ground truth used (expert consensus, pathology, outcomes data). While "functional performance was validated" and "cleaning validation," etc., are mentioned, these are for a reprocessing procedure, not for establishing ground truth for an AI model's output.
    • Sample size for the training set (for an AI model).
    • How the ground truth for the training set was established (for an AI model).

    In summary, the provided text describes the regulatory approval of a reprocessed physical medical device (endoscopic trocar) through a 510(k) submission, not the evaluation of an AI/ML medical device. Therefore, it does not contain the information requested in your bullet points, which are tailored for AI/ML device studies.

    Ask a Question

    Ask a specific question about this device

    K Number
    K063788
    Date Cleared
    2007-10-15

    (298 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    REPROCESSED ENDOSCOPIC TROCARS AND CANNULAS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Reprocessed Endoscopic Trocars are indicated for use to establish a port of entry for endoscopic instruments in patients requiring minimally invasive surgical procedures.

    Device Description

    Reprocessed Endoscopic Trocars and Cannulas are designed to establish a port of entry for endoscopic instruments used during minimally invasive surgery. Endoscopic trocars and cannulas are available in a variety of configurations and materials as well as trocar and cannula sets. Trocar seals vary between single-port and multi-port seals.

    AI/ML Overview

    Acceptance Criteria and Study for Reprocessed Endoscopic Trocars and Cannulas

    1. Table of Acceptance Criteria and Reported Device Performance:

    The document describes the submission as a "Traditional 510(k)" and focuses on demonstrating substantial equivalence to predicate devices rather than setting and meeting specific quantitative acceptance criteria for novel performance. Therefore, the "acceptance criteria" here are qualitative, based on the device performing "as originally intended" and being "safe and effective."

    Acceptance Criteria (Qualitative)Reported Device Performance (Qualitative)
    Device performs as originally intended."Performance testing demonstrates that Reprocessed Endoscopic Trocars and Cannulas perform as originally intended."
    Device is safe and effective."Ascent Healthcare Solutions concludes that the modified devices (Reprocessed Endoscopic Trocars and Cannulas) are safe, effective, and substantially equivalent to the predicate devices as described herein." This is supported by bench and laboratory testing in the following areas: Biocompatibility, Validation of reprocessing, Sterilization Validation, Function test(s), Packaging Validation. The device retains the same design, materials, intended use, mechanism of action, performance specifications, and method of operation as the original (predicate) devices. Reprocessing includes removal of visible soil and decontamination.
    Substantial equivalence to predicate devices (K041795, K032889, K012884, K012968)."The design, materials, and intended use of Reprocessed Technological Endoscopic Trocars and Cannulas are identical to the predicate characteristics: devices. The mechanism of action of Reprocessed Endoscopic Trocars and Cannulas is identical to the predicate devices in that the same standard mechanical design, materials, and sizes are utilized. There are no changes to the claims, intended use, clinical applications, patient population, performance specifications, or method of operation."

    2. Sample Size Used for the Test Set and Data Provenance:

    The document does not specify a numerical sample size for "test sets" in the traditional sense of a clinical trial. Instead, it refers to "bench and laboratory testing." The provenance of the data is from laboratory testing conducted by Ascent Healthcare Solutions. It is retrospective in the sense that the goal is to demonstrate that reprocessed devices match the performance of already-marketed devices. No information on country of origin of the data is provided beyond the applicant being a US-based company.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:

    This information is not provided in the document. The nature of the testing (biocompatibility, reprocessing validation, sterilization validation, function tests, packaging validation) suggests internal engineering and scientific expertise rather than clinical expert consensus on a test set of cases.

    4. Adjudication Method for the Test Set:

    This information is not provided and is not applicable to the type of bench and laboratory testing described. Adjudication methods like 2+1 or 3+1 are typically used for clinical image interpretation or diagnostic decisions, which is not what was performed for this device.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance:

    An MRMC comparative effectiveness study was not performed, nor is it applicable. This device is a reprocessed medical instrument (trocar and cannula), not an AI-powered diagnostic or assistive tool.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done:

    Standalone algorithm performance studies were not performed, nor are they applicable. This device is a physical medical instrument, not an algorithm.

    7. The Type of Ground Truth Used:

    The "ground truth" for this submission is implicitly the performance of the original, new predicate devices. The testing aims to demonstrate that the reprocessed devices achieve the same level of performance and safety characteristics as the original devices. This is established through:

    • Biocompatibility testing: To ensure the materials remain safe after reprocessing.
    • Validation of reprocessing: To confirm the reprocessing methods effectively clean and prepare the device.
    • Sterilization Validation: To confirm the device is sterile after reprocessing.
    • Function test(s): To ensure mechanical and operational integrity matches the original device.
    • Packaging Validation: To ensure the device remains sterile and functional until use.

    8. The Sample Size for the Training Set:

    This information is not provided and is not applicable. This submission concerns a reprocessed medical device, not a machine learning model that requires a training set. The "training" for this device would refer to the validation of the reprocessing protocol itself, which would involve a sufficient number of devices to demonstrate consistency in the reprocessing method's effectiveness.

    9. How the Ground Truth for the Training Set Was Established:

    This information is not provided and not applicable as there is no "training set" in the machine learning sense. The "ground truth" for validating the reprocessing process would be established through industry standards, regulatory guidelines (e.g., for sterilization and cleaning), and laboratory measurements indicating the absence of contaminants, proper material integrity, and functionality that matches the new device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K060676
    Date Cleared
    2007-09-07

    (542 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    NES REPROCESSED ENDOSCOPIC TROCAR

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Reprocessed Endoscopic Trocars are indicated for use to establish a port of entry for endoscopic instruments in patients requiring minimally invasive surgical procedures.

    Device Description

    Trocars are devices inserted into a patient in order to maintain a clear pathway to facilitate the insertion of various surgical tools. Trocars are designed in both bladed and non-bladed configurations, however this submission is for non-bladed B5LTs. Non-bladed trocars require an incision be made before insertion into the patient's cavity. Trocars have a luer stopcock port for insufflation and desufflation of the patient's cavity. NES Reprocessed Endoscopic Trocars are sent from a user facility to be cleaned, sterilized and repackaged by NES. NES Reprocessed Endoscopic Trocars have the same intended use and performance characteristics equivalent to Endoscopic Trocars provided by Original Equipment Manufacturers (OEM).

    AI/ML Overview

    The provided text describes the regulatory submission for a reprocessed medical device, the "NES Reprocessed Endoscopic Trocar." The focus of the submission is to demonstrate that the reprocessed device is substantially equivalent to legally marketed predicate devices. This type of submission relies on demonstrating that the reprocessed device meets the same performance characteristics as the original, rather than establishing acceptance criteria for a novel algorithm or AI system.

    Therefore, the information requested regarding acceptance criteria and a study proving a device meets those criteria in the context of an algorithm's performance is largely not applicable to this document. The document focuses on showing that the reprocessed physical device has equivalent performance, safety, and effectiveness to its original, non-reprocessed counterpart.

    Here's an analysis of the provided text in relation to your questions, highlighting why most are not directly addressed:

    1. A table of acceptance criteria and the reported device performance

    • Not applicable in the typical sense for an algorithm. For a reprocessed physical device like a trocar, the "acceptance criteria" are generally that it functions identically and safely to the original device. This is demonstrated through various physical, chemical, and biological tests, not statistical performance metrics of an algorithm.
    • The document states: "NES Reprocessed Endoscopic Trocars have the same intended use and performance characteristics equivalent to Endoscopic Trocars provided by Original Equipment Manufacturers (OEM)." and "NES Reprocessed Endoscopic Trocars operate as originally intended and are safe, effective and sterile as demonstrated by cleaning, packaging, performance, sterilization and biocompatibility testing."
    • Implied Acceptance Criteria (based on the text):
      • Functionality: Operates "as originally intended" and has "performance characteristics equivalent" to OEM. This would be assessed through mechanical testing (e.g., insertion force, structural integrity, insufflation seal).
      • Safety: Demonstrated by "biocompatibility testing."
      • Effectiveness: Functions as intended for its "intended use" (establishing a port of entry). This is a broad claim supported by the functionality.
      • Sterility: Demonstrated by "sterilization testing."
      • Cleaning/Reprocessing Efficacy: Demonstrated by "cleaning, packaging" assessments.

    2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Not explicitly mentioned. The document refers to "testing" but does not provide specific sample sizes for each type of test conducted (e.g., how many reprocessed trocars were tested for strength, sterility, or biocompatibility).
    • Data Provenance: Not specified. It's implied that the testing was performed by Northeast Scientific, Inc., likely in the USA given their address.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    • Not applicable. There is no "ground truth" in the algorithmic sense. The "ground truth" for a physical device's performance is typically established by engineering specifications, material science standards, and established medical device performance criteria, often determined by industry standards and regulatory guidance for reprocessed devices. The testing is objective against these standards, not against expert human interpretations.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    • Not applicable. Adjudication methods like 2+1 or 3+1 are used for resolving disagreements in expert interpretations, typically in diagnostic imaging or clinical trials involving subjective assessments. The tests for a medical device like a trocar are objective (e.g., tensile strength, leak rate, sterility tests), so adjudication by human experts is not relevant.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • Not applicable. This device is a physical medical instrument (trocar), not an AI algorithm. Therefore, an MRMC study or AI assistance is irrelevant.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Not applicable. This is a physical device, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    • Objective testing against predetermined physical, chemical, and biological standards. For a reprocessed device, the "ground truth" for showing substantial equivalence relies on proving that the reprocessed device performs identically to the original OEM device under various conditions (e.g., mechanical strength, sterility, biocompatibility). These are derived from established engineering and biological standards, not from expert consensus or pathology on a specific case.

    8. The sample size for the training set

    • Not applicable. This device is a reprocessed physical instrument, not an AI algorithm that requires a training set.

    9. How the ground truth for the training set was established

    • Not applicable. As above, no training set for an AI algorithm.

    Summary regarding the provided text (K060676):

    The document is a 510(k) summary for a reprocessed medical device. The "study" referenced is a series of tests to demonstrate that the reprocessed device meets the performance and safety characteristics of its original, non-reprocessed counterpart. These tests (cleaning, packaging, performance, sterilization, and biocompatibility) are designed to show substantial equivalence, not to prove the statistical performance of an AI algorithm against specific acceptance criteria in the manner you've outlined in your questions. Therefore, most of your specific questions are not directly answerable or applicable from this regulatory submission.

    Ask a Question

    Ask a specific question about this device

    K Number
    K052299
    Manufacturer
    Date Cleared
    2006-05-23

    (272 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    REPROCESSED ENDOSCOPIC TROCAR

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The reprocessed endoscopic trocars are designed to provide a pathway for entry of minimally invasive instruments to a body organ or cavity during general, abdominal, thoracic, gynecologic or other minimally invasive surgical procedures.

    Device Description

    The Reprocessed Endoscopic Trocar is a sterile instrument consisting of a radiolucent sleeve and obturator in sizes ranging from 75 to 150 mm in length and 5 to 12 mm in diameter. Reprocessed Endoscopic Trocars are devices that provide a pathway for entry of minimally invasive instruments to a body organ or cavity during abdominal, thoracic or gynecologic surgical procedures.

    AI/ML Overview

    The provided text describes the 510(k) summary for SterilMed, Inc.'s Reprocessed Endoscopic Trocar. However, it does not contain specific acceptance criteria or a detailed study description with performance metrics in the format requested.

    The document primarily focuses on establishing substantial equivalence to predicate devices based on functional design, materials, indications for use, and manufacturing methods. It mentions "Functional and Safety Testing" and "Process validation testing" but does not elaborate on the specific acceptance criteria or the quantitative results of these tests.

    Therefore, the following information is not available in the provided text:

    • A table of acceptance criteria and reported device performance.
    • Sample sizes used for test sets.
    • Data provenance (country of origin, retrospective/prospective).
    • Number and qualifications of experts for ground truth.
    • Adjudication method for test set.
    • Results of a multi-reader multi-case (MRMC) comparative effectiveness study.
    • Results of a standalone (algorithm only) performance study.
    • Type of ground truth used (expert consensus, pathology, outcomes data, etc.) for testing.
    • Sample size for the training set.
    • How ground truth for the training set was established.

    Summary of available information:

    1. Acceptance Criteria and Device Performance:

    The document states: "Representative samples of reprocessed endoscopic trocars underwent bench testing to demonstrate appropriate functional performance. Process validation testing was performed to validate the cleaning and sterilization procedures as well as the device's packaging. In addition, the manufacturing process includes visual and functional testing of all products produced."

    It concludes that the device is "substantially equivalent" to predicate devices based on "similarities in functional design, materials, indications for use and methods of construction."

    No specific quantitative acceptance criteria or corresponding performance scores are provided in the text.

    2. Sample size used for the test set and the data provenance:

    • Sample Size: Not specified. The document mentions "Representative samples," but does not give a number.
    • Data Provenance: Not specified.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not applicable as this is a medical device, not an AI/imaging device requiring expert ground truth for classification. The testing focused on functional performance, cleaning, and sterilization validation.

    4. Adjudication method for the test set:

    • Not applicable.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • Not applicable. This is not an AI-assisted diagnostic device.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

    • Not applicable. This is not an AI algorithm.

    7. The type of ground truth used:

    • For "Functional and Safety Testing," the ground truth would be established scientific and engineering standards for device performance, cleanliness, and sterility. These are typically defined by regulatory standards (e.g., ISO, ASTM) and internal specifications. The document doesn't explicitly state the specific standards used.

    8. The sample size for the training set:

    • Not applicable. This device is reprocessed hardware, not an AI model requiring a training set.

    9. How the ground truth for the training set was established:

    • Not applicable.
    Ask a Question

    Ask a specific question about this device

    K Number
    K043592
    Manufacturer
    Date Cleared
    2005-05-23

    (145 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    REPROCESSED ENDOSCOPIC TROCAR

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The reprocessed endoscopic trocars are designed to provide a pathway for entry of minimally invasive instruments to a body organ or cavity during general, abdominal, thoracic, gynecologic or other minimally invasive surgical procedures.

    Device Description

    Reprocessed endoscopic trocars are devices that provide a pathway for entry of minimally invasive instruments to a body organ or cavity during general, abdominal, thoracic, gynecologic or other minimally invasive surgical procedures such as observation, dissecting, cutting, repairing, and removal or manipulation of internal tissues and/or organs. Reprocessed endoscopic trocars are of varying lengths and diameters, and may have either a blunt or bladed obturator tip.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information based on the provided document:

    Acceptance Criteria and Device Performance

    Acceptance CriteriaReported Device Performance
    Appropriate functional characteristicsBench testing demonstrated appropriate functional characteristics.
    BiocompatibilityBiocompatibility testing demonstrated compatibility of the device materials.
    Validated cleaning and sterilization proceduresProcess validation testing validated the cleaning and sterilization procedures.
    Validated device packagingProcess validation testing validated the device packaging.
    Visual and functional quality (during manufacturing)The manufacturing process includes visual and functional testing of all products produced.

    Note: The document states that the reprocessed endoscopic trocars are "substantially equivalent" to predicate devices. This implies that the acceptance criteria are met if the reprocessed device performs comparably to the original, legally marketed devices. Specific numerical thresholds or detailed performance metrics for "appropriate functional characteristics" or "biocompatibility" are not provided.

    Study Details

    This submission is for a reprocessed device, and the "study" described focuses on demonstrating equivalence to predicate devices through functional, biocompatibility, and process validation testing rather than a traditional comparative clinical trial with human subjects.

    1. Sample sizes used for the test set and the data provenance:

      • Test set sample size: Not explicitly stated as a single numerical value. The document mentions "Representative samples of reprocessed endoscopic trocars" were used for bench testing. The specific number of trocars tested is not provided.
      • Data provenance: Not specified, but likely from internal laboratory testing conducted by SterilMed, Inc. It is retrospective in the sense that they are re-evaluating existing devices after reprocessing, but the testing itself is prospective (performed for this submission).
      • Country of origin of the data: Not explicitly stated, but the submitter (SterilMed, Inc.) is based in Minneapolis, Minnesota, USA, implying the data is likely from the USA.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • This type of information is generally not applicable to a premarket notification (510(k)) for a reprocessed device where the focus is on functional equivalence and safety rather than a diagnostic performance study. The "ground truth" here is the established performance and safety profile of the predicate devices. Experts involved would likely be those conducting the functional, biocompatibility, and process validation testing (e.g., engineers, microbiologists, quality control specialists), but their number and specific qualifications are not detailed.
    3. Adjudication method for the test set:

      • Not applicable/described. Adjudication methods like 2+1 or 3+1 are typically used in clinical studies involving interpretation of medical images or patient outcomes, which is not the nature of this submission. The "adjudication" here would be the scientific assessment by the testing personnel and quality assurance to determine if the test results meet internal and regulatory standards.
    4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No. An MRMC comparative effectiveness study is not applicable as this is a medical device for surgical procedures (trocars), not an AI-powered diagnostic tool for human readers.
    5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

      • No. This is a physical medical device, not an algorithm or AI system.
    6. The type of ground truth used:

      • The "ground truth" for this submission is implicitly the established performance and safety of the predicate devices (Ethicon Endopath EP Disposable Surgical Trocar and AutoSuture Surgiport® Endoscopic Trocar). The reprocessed device is deemed acceptable if its functional characteristics, biocompatibility, and sterilization/packaging validation data demonstrate that it performs substantially equivalently to these legally marketed devices.
    7. The sample size for the training set:

      • Not applicable. This is not an AI/machine learning device that requires a training set. The "training" for the reprocessing procedures would involve process development and validation, but not in the context of a dataset for an algorithm.
    8. How the ground truth for the training set was established:

      • Not applicable. See point 7.
    Ask a Question

    Ask a specific question about this device

    K Number
    K024015
    Date Cleared
    2003-03-04

    (90 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    REPROCESSED ENDOSCOPIC TROCARS AND CANNULAS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Reprocessed Endoscopic Trocars and Cannulas are indicated for use to establish a port of entry for endoscopic instruments in patients requiring minimally invasive surgical procedures.

    Device Description

    Reprocessed Endoscopic Trocars and Cannulas. The submission includes a list of specific Endoscopic Trocars and Cannulas from manufacturers US Surgical, Auto Suture, and Ethicon that will be reprocessed.

    AI/ML Overview

    The provided document is a 510(k) clearance letter for reprocessed endoscopic trocars and cannulas. It does not contain information about acceptance criteria for an AI/device performance study, nor does it describe a study that proves a device meets such criteria.

    The letter from the FDA (dated March 3, 2006) refers to a "supplemental validation data as required for reprocessed single-use devices by the Medical Device User Fee and Modernization Act of 2002." This "validation data" would relate to the reprocessing of medical devices to ensure they are safe and effective for reuse, not to the performance of an AI or diagnostic device.

    Therefore, I cannot provide the requested information as it is not present in the given text.

    To be clear:

    • 1. A table of acceptance criteria and the reported device performance: Not available. The document is about reprocessing medical devices, not an AI device or a performance study.
    • 2. Sample sized used for the test set and the data provenance: Not available.
    • 3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not available.
    • 4. Adjudication method: Not available.
    • 5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not available.
    • 6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not available.
    • 7. The type of ground truth used: Not available.
    • 8. The sample size for the training set: Not available.
    • 9. How the ground truth for the training set was established: Not available.
    Ask a Question

    Ask a specific question about this device

    K Number
    K012578
    Manufacturer
    Date Cleared
    2001-11-07

    (90 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    REPROCESSED ENDOSCOPIC TROCAR

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The reprocessed endoscopic trocars are intended to provide a pathway for entry of minimally invasive instruments to a body organ or cavity during general, abdominal, thoracic, gynecological or other minimally invasive surgical procedures.

    Device Description

    Reprocessed endoscopic trocars are devices that provide a pathway for entry of minimally invasive instruments to a body organ or cavity during general, abdominal, thoracic, gynecologic or other minimally invasive surgical procedures such as observation, dissecting, cutting, repairing, and removal or manipulation of internal tissues and/or organs. Reprocessed endoscopic trocars are of varying lengths and diameters, and may have either a blunt or bladed obturator tip.

    AI/ML Overview

    The provided text is a 510(k) premarket notification letter and summary for reprocessed endoscopic trocars. It discusses the substantial equivalence of the reprocessed devices to legally marketed predicate devices. However, it does not contain a detailed study with specific acceptance criteria, reported device performance metrics, sample sizes for test or training sets, ground truth establishment, or expert information as requested in the prompt.

    The document mentions "Functional and Safety Testing" and "Process validation testing" were done, but it does not provide the results, specific acceptance criteria, or methodology of these tests in a format that lends itself to answering the detailed questions about a study comparing AI performance or standalone algorithm performance.

    Therefore, I cannot fulfill the request for information on acceptance criteria and a study that proves the device meets them based on the provided text. The text primarily focuses on regulatory approval based on substantial equivalence to predicate devices, rather than a detailed performance study with quantifiable results against specific criteria.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1